These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15802690)

  • 1. Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial.
    Valmaggia LR; van der Gaag M; Tarrier N; Pijnenborg M; Slooff CJ
    Br J Psychiatry; 2005 Apr; 186():324-30. PubMed ID: 15802690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication.
    Sensky T; Turkington D; Kingdon D; Scott JL; Scott J; Siddle R; O'Carroll M; Barnes TR
    Arch Gen Psychiatry; 2000 Feb; 57(2):165-72. PubMed ID: 10665619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive-behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China.
    Li ZJ; Guo ZH; Wang N; Xu ZY; Qu Y; Wang XQ; Sun J; Yan LQ; Ng RM; Turkington D; Kingdon D
    Psychol Med; 2015 Jul; 45(9):1893-905. PubMed ID: 25532460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group cognitive-behavioural therapy for schizophrenia. Randomised controlled trial.
    Barrowclough C; Haddock G; Lobban F; Jones S; Siddle R; Roberts C; Gregg L
    Br J Psychiatry; 2006 Dec; 189():527-32. PubMed ID: 17139037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial.
    Morrison AP; Hutton P; Wardle M; Spencer H; Barratt S; Brabban A; Callcott P; Christodoulides T; Dudley R; French P; Lumley V; Tai SJ; Turkington D
    Psychol Med; 2012 May; 42(5):1049-56. PubMed ID: 21914252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
    Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
    JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metacognitive training for schizophrenia: a multicentre randomised controlled trial.
    Briki M; Monnin J; Haffen E; Sechter D; Favrod J; Netillard C; Cheraitia E; Marin K; Govyadovskaya S; Tio G; Bonin B; Chauvet-Gelinier JC; Leclerc S; Hodé Y; Vidailhet P; Berna F; Bertschy AZ; Vandel P
    Schizophr Res; 2014 Aug; 157(1-3):99-106. PubMed ID: 24972754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up.
    Durham RC; Guthrie M; Morton RV; Reid DA; Treliving LR; Fowler D; Macdonald RR
    Br J Psychiatry; 2003 Apr; 182():303-11. PubMed ID: 12668405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
    Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
    Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms.
    Moritz S; Veckenstedt R; Randjbar S; Vitzthum F; Woodward TS
    Psychol Med; 2011 Sep; 41(9):1823-32. PubMed ID: 21275083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive behavioural therapy for auditory hallucinations: effectiveness and predictors of outcome in a specialist clinic.
    Thomas N; Rossell S; Farhall J; Shawyer F; Castle D
    Behav Cogn Psychother; 2011 Mar; 39(2):129-38. PubMed ID: 21062528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive-behavioral therapy for medication-resistant schizophrenia: a review.
    Rathod S; Kingdon D; Weiden P; Turkington D
    J Psychiatr Pract; 2008 Jan; 14(1):22-33. PubMed ID: 18212600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotic Symptoms and Attitudes toward Medication Mediate the Effect of Insight on Personal-Social Functions in Patients with Schizophrenia: One-Year Randomized Controlled Trial and Follow-Up.
    Zheng Y; Ning Y; She S; Deng Y; Chen Y; Yi W; Lu X; Chen X; Li J; Li R; Zhang J; Xiao D; Wu H; Wu C
    Psychopathology; 2018; 51(3):167-176. PubMed ID: 29444522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of the effects of cognitive-behavioural therapy in the treatment of chronic schizophrenia: 12-month follow-up.
    Tarrier N; Wittkowski A; Kinney C; McCarthy E; Morris J; Humphreys L
    Br J Psychiatry; 1999 Jun; 174():500-4. PubMed ID: 10616627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognitive behavioural therapy for schizophrenia].
    Smits CT; van der Gaag M
    Tijdschr Psychiatr; 2010; 52(2):99-109. PubMed ID: 20146181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial.
    Tarrier N; Lewis S; Haddock G; Bentall R; Drake R; Kinderman P; Kingdon D; Siddle R; Everitt J; Leadley K; Benn A; Grazebrook K; Haley C; Akhtar S; Davies L; Palmer S; Dunn G
    Br J Psychiatry; 2004 Mar; 184():231-9. PubMed ID: 14990521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials.
    Goff DC; Keefe R; Citrome L; Davy K; Krystal JH; Large C; Thompson TR; Volavka J; Webster EL
    J Clin Psychopharmacol; 2007 Dec; 27(6):582-9. PubMed ID: 18004124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes.
    Lewis S; Tarrier N; Haddock G; Bentall R; Kinderman P; Kingdon D; Siddle R; Drake R; Everitt J; Leadley K; Benn A; Grazebrook K; Haley C; Akhtar S; Davies L; Palmer S; Faragher B; Dunn G
    Br J Psychiatry Suppl; 2002 Sep; 43():s91-7. PubMed ID: 12271807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.